| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 1/6 |
| Dividends | 2/6 |
Spire Healthcare Group plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£2.74 |
| 52 Week High | UK£3.08 |
| 52 Week Low | UK£2.28 |
| Beta | 0.98 |
| 11 Month Change | -4.86% |
| 3 Month Change | 6.20% |
| 1 Year Change | 17.09% |
| 33 Year Change | 3.79% |
| 5 Year Change | 122.40% |
| Change since IPO | 5.38% |
Recent News & Updates
Recent updates
Shareholder Returns
| S00 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 1.5% | 2.5% | 0.9% |
| 1Y | 17.1% | 4.1% | 5.7% |
Return vs Industry: S00 exceeded the German Healthcare industry which returned 4.1% over the past year.
Return vs Market: S00 exceeded the German Market which returned 5.7% over the past year.
Price Volatility
| S00 volatility | |
|---|---|
| S00 Average Weekly Movement | 5.2% |
| Healthcare Industry Average Movement | 5.2% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: S00 has not had significant price volatility in the past 3 months.
Volatility Over Time: S00's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 12,787 | Justin Ash | www.spirehealthcare.com |
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.
Spire Healthcare Group plc Fundamentals Summary
| S00 fundamental statistics | |
|---|---|
| Market cap | €1.15b |
| Earnings (TTM) | €32.28m |
| Revenue (TTM) | €1.61b |
35.6x
P/E Ratio0.7x
P/S RatioIs S00 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| S00 income statement (TTM) | |
|---|---|
| Revenue | UK£1.36b |
| Cost of Revenue | UK£734.80m |
| Gross Profit | UK£624.20m |
| Other Expenses | UK£596.90m |
| Earnings | UK£27.30m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 12, 2024
| Earnings per share (EPS) | 0.068 |
| Gross Margin | 45.93% |
| Net Profit Margin | 2.01% |
| Debt/Equity Ratio | 49.5% |
How did S00 perform over the long term?
See historical performance and comparison